Voloridge Investment Management
ACOR

Voloridge Investment Management’s Acorda Therapeutics ACOR Stock Holding History

Voloridge Investment Management’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-609
Closed -$149K – 1485
2019
Q4 		$149K Buy
+609
New +$154K ﹤0.01% 1020
2019
Q3 		– Sell
-718
Closed -$661K – 1258
2019
Q2 		$661K Buy
+718
New +$882K 0.02% 527
2016
Q2 		– Sell
-506
Closed -$1.61M – 422
2016
Q1 		$1.61M Buy
+506
New +$2.1M 0.04% 225

Other funds holding ACOR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Voloridge Investment Management's ACOR Position: Q1 2020 in Review

Voloridge Investment Management sold out of Acorda Therapeutics (ACOR) in Q1 2020, closing a stake of 609 shares — an estimated $149K sold.

Voloridge Investment Management first reported a position in ACOR in Q1 2016 and held it in 3 quarters. The position peaked at $1.61M in Q1 2016. 106 funds tracked by Wall St. Rank hold ACOR as of Q1 2020.

  • Voloridge Investment Management reported no remaining Acorda Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Voloridge Investment Management sold 609 Acorda Therapeutics shares in Q1 2020, an estimated $149K.
  • Voloridge Investment Management first reported a position in Acorda Therapeutics in Q1 2016 and held it in 3 quarters.
  • Voloridge Investment Management's Acorda Therapeutics position peaked at $1.61M in Q1 2016.
  • 106 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q1 2020.

Based on Voloridge Investment Management's 13F filing for Q1 2020, filed 15 May 2020.